Open Biology's Quest to Explode Data

By John Wilbanks Open Biology’s Quest to Explode Data A “science commons” at the data-intensive layer will encourage scholarly collaboration and communication—and spur drug discovery. “Network of Networkers” by Alex Pico using the Cytoscape gene network tool. Robert Metcalfe, co-inventor of Ethernet and the founder of 3Com, observed that the value of a telecommunications network is proportional to the square of the numbe

Written byJohn Wilbanks
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Robert Metcalfe, co-inventor of Ethernet and the founder of 3Com, observed that the value of a telecommunications network is proportional to the square of the number of connected users of the system. This is known as Metcalfe’s Law, and it goes a long way toward explaining why we can create and realize so much value from the Web. As more users get online, the network gets more valuable, spurring more users to get online, and so on.

Getting Metcalfe’s Law to operate for data is a long-held goal of science. Indeed, the Web was created to share data—physics data—by making it easier to link, find, download, and browse information on disparate computers. But we don’t have the functionality of the consumer Web for biological data. And we’re not getting network effects for data in the spaces that would most dramatically affect our lives—in the study of human disease.

Three New ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies